0001185185-25-001203
SEC filingFrequency Electronics reported a sharp decline in Q1 FY2026 net income to $0.6 million from $2.4 million, driven by lower revenue and compressed gross margins.
For the three months ended July 31, 2025, Frequency Electronics reported consolidated revenue of $13.8 million, an 8.4% decrease from $15.1 million in the same period last year. The decline was primarily driven by customer-imposed program delays, particularly in the satellite and FEI-Zyfer segments. Management noted that these delays are not expected to result in permanent revenue reductions, as the shortfalls are anticipated to be realized in upcoming quarters, predominantly within the current fiscal year.
Gross profit fell 24.1% to $5.1 million, and the gross margin rate contracted sharply to 36.8% from 44.4% in the prior-year quarter. The compression was attributed to quarterly fluctuations in the mix of business activity between higher-margin programs and lower-margin programs, including cumulative catch-up adjustments for some ongoing programs.
Operating income decreased 84.6% to $0.4 million, reflecting the lower revenue and gross margin, as well as a 26.0% increase in selling, general, and administrative (SG&A) expenses to $3.6 million. The SG&A increase was driven by higher payroll-related expenses, including stock compensation, and investments in future growth initiatives such as expansion into Colorado and Quantum sensing.
Net income fell 73.9% to $0.6 million ($0.07 per share) from $2.4 million ($0.25 per share) in the prior-year quarter. The decline was partially offset by an income tax benefit of $77,270, compared to a provision of $132,930 in the prior year, primarily due to a discrete income tax benefit of $193,919 from stock compensation windfall tax benefits.
As of July 31, 2025, the company maintained a strong working capital position of approximately $29.6 million, essentially flat compared to $29.7 million at April 30, 2025. Cash and cash equivalents totaled $4.5 million, down from $4.7 million at the end of the prior quarter. The current ratio remained stable at 2.3 to 1.
Total assets decreased slightly to $93.2 million from $93.7 million at April 30, 2025. Key changes included a decrease in contract assets to $14.2 million from $17.9 million, and an increase in accounts receivable to $7.4 million from $5.9 million. Inventories increased to $24.8 million from $23.5 million.
Total liabilities decreased to $36.9 million from $38.1 million, primarily due to a reduction in contract liabilities to $13.1 million from $13.6 million and a decrease in the loss provision accrual to $0.1 million from $0.5 million.
Stockholders' equity increased to $56.3 million from $55.6 million, driven by net income of $0.6 million and stock-based compensation of $0.4 million, partially offset by treasury stock purchases of $0.6 million.
Net cash provided by operating activities was $1.2 million in the current quarter, compared to net cash used in operating activities of $1.5 million in the prior-year period. The improvement was primarily due to timing of billings and cash collections. Non-cash charges to earnings were $1.3 million in both periods, including amortization of ROU assets, depreciation, inventory adjustments, deferred compensation, and employee benefit accruals.
Capital expenditures totaled $0.8 million, up from $0.3 million in the prior-year quarter, reflecting investments in fixed assets. Free cash flow (operating cash flow minus capex) was approximately $0.4 million, compared to negative $1.8 million in the prior year.
The company's liquidity position is considered adequate to meet short-term operating and investment needs through at least September 15, 2026, and for the foreseeable future thereafter.
Management attributed the revenue decline to customer-imposed program delays, which are expected to reverse in upcoming quarters. The company continues to invest in R&D to maintain its competitive edge in time and frequency technology, with R&D expenses of $1.1 million in the quarter, down from $1.5 million in the prior year.
The company's consolidated funded backlog was approximately $71 million as of July 31, 2025, compared to $70 million at April 30, 2025. Approximately 64% of the backlog is expected to be realized in the next twelve months.
On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) was signed into law, which allows full deduction of domestic research expenditures for tax years beginning after December 31, 2024, and provides a permanent provision for 100% bonus depreciation. The company determined that the enactment did not have a material impact on its provision or effective tax rate as of July 31, 2025.
The estimated annual effective tax rate for fiscal year ending April 30, 2026 is 20.96%, reflecting non-deductible expenses, estimated R&D credits, and state income taxes.
Segment Performance:
Revenue by Product Line:
Revenue Recognition: Total revenue recognized over time as Percentage of Completion (POC) was $12.4 million, and as Passage of Title (POT) was $1.4 million, compared to $14.5 million and $0.6 million, respectively, in the prior year.
Investment in Morion, Inc.: The company's 4.6% investment in Morion, a Russian company, was fully written off in fiscal year 2022. On October 30, 2024, the U.S. Treasury's OFAC designated Morion as a Specially Designated National, leading to the termination of all commercial relationships. The company has established alternate supply sources and can fabricate crystal blanks in-house.
Stock-Based Compensation: Stock-based compensation expense was $0.4 million in the current quarter, compared to $0.3 million in the prior year. The company also contributed 12,405 shares of common stock to its 401(k) plan, valued at $0.3 million.
Share Repurchases: During the quarter, the company acquired 21,910 shares at a weighted average price of $26.60 per share for tax withholding obligations related to RSUs. As of July 31, 2025, approximately $0.6 million remained available under the $5.0 million board-authorized repurchase program.